Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FC6H3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,044
Award facts
- Contract value 100% obligated
- $40,044.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,044.00 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/1.2 mL powder vials. This non-competitive delivery order was issued on June 2, 2025, with an ultimate completion date of June 24, 2025, and represents a firm fixed-price procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026 that provides comprehensive pharmaceutical and medical supply support for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in federal medical procurement through the DLA's supply chain. The company's extensive portfolio of federal contracts demonstrates expertise in delivering a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems. As a child contract under the larger SPE2DX IDC, this delivery order exemplifies the company's role as a critical vendor fulfilling federal military healthcare pharmaceutical requirements through competitively established framework agreements.
Quick answers
Who was awarded contract SPE2DB25FC6H3?
SPE2DB25FC6H3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FC6H3 worth?
The government has obligated $40,044 on SPE2DB25FC6H3.
Is contract SPE2DB25FC6H3 an order under another contract?
Yes. SPE2DB25FC6H3 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC6H3 competed?
The extent of competition for SPE2DB25FC6H3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award